Literature DB >> 10582843

Acute complications in the operative treatment of isolated ankle fractures in patients with diabetes mellitus.

R H Blotter1, E Connolly, A Wasan, M W Chapman.   

Abstract

Using a computer database, we conducted a retrospective review of all ankle fractures treated at our institution from March 1985 to October 1996. Twenty-one patients with diabetes mellitus and isolated ankle fractures that were treated operatively met all inclusion criteria. Seven had insulin-dependent diabetes, and 14 had non-insulin-dependent diabetes. A randomly selected control group of 46 patients without diabetes who also underwent operative treatment of ankle fractures during this same time period were matched for age, sex, and fracture severity. The complication rate was 43% with 13 complications in nine patients with diabetes. There were seven (15.5%) complications in the control group. Complications in the diabetic group included seven infections (five deep, two superficial) and three losses of fixation. The complications were more severe in our diabetic population, requiring seven additional procedures including two below-knee amputations; a third patient refused an amputation. No additional procedures were required in our control group. All complications in our control group resolved with treatment. The relative risk for postoperative complications in patients with diabetes who sustained ankle fractures that were treated operatively was 2.76 times greater than the control group's (95% confidence interval, 1.57-3.97).

Entities:  

Mesh:

Year:  1999        PMID: 10582843     DOI: 10.1177/107110079902001103

Source DB:  PubMed          Journal:  Foot Ankle Int        ISSN: 1071-1007            Impact factor:   2.827


  13 in total

1.  Glycemic control and fracture risk in elderly patients with diabetes.

Authors:  Baqiyyah N Conway; Dustin M Long; M Kathleen Figaro; Michael E May
Journal:  Diabetes Res Clin Pract       Date:  2016-03-12       Impact factor: 5.602

2.  Risk factors of deep infection in operatively treated pilon fractures (AO/OTA: 43).

Authors:  Cesar S Molina; Daniel J Stinner; Andrew R Fras; Jason M Evans
Journal:  J Orthop       Date:  2015-02-21

Review 3.  Special Considerations in the Management of Diabetic Ankle Fractures.

Authors:  Jeffrey M Manway; Cody D Blazek; Patrick R Burns
Journal:  Curr Rev Musculoskelet Med       Date:  2018-09

4.  Percutaneous injection of bone marrow mesenchymal stem cells for ankle non-unions decreases complications in patients with diabetes.

Authors:  Philippe Hernigou; Isaac Guissou; Yasuhiro Homma; Alexandre Poignard; Nathalie Chevallier; Helene Rouard; Charles Henri Flouzat Lachaniette
Journal:  Int Orthop       Date:  2015-03-22       Impact factor: 3.075

5.  [Ankle osteosynthesis infection: vacuum therapy as the treatment of choice].

Authors:  Y Kollrack; G Möllenhoff
Journal:  Unfallchirurg       Date:  2009-04       Impact factor: 1.000

6.  What are the patterns of prophylactic postoperative oral antibiotic use after foot and ankle surgery?

Authors:  David J Ruta; Anish R Kadakia; Todd A Irwin
Journal:  Clin Orthop Relat Res       Date:  2014-06-19       Impact factor: 4.176

7.  Current concepts and challenges in managing ankle fractures in the presence of diabetes: A systematic review of the literature.

Authors:  William J Nash; Thomas Hester; Joon Ha
Journal:  J Clin Orthop Trauma       Date:  2021-02-03

8.  Diabetic ankle fractures: a review of the literature and an introduction to the Adelaide fracture in the diabetic ankle algorithm and score.

Authors:  Joshua Yee; Anand Pillai; Linda Ferris
Journal:  Biomed Res Int       Date:  2014-01-05       Impact factor: 3.411

9.  Complication rates in diabetics with first metatarsophalangeal joint arthrodesis.

Authors:  John J Anderson; Myron Hansen; Gregory Paul Rowe; Zflan Swayzee
Journal:  Diabet Foot Ankle       Date:  2014-06-27

10.  The BB Wistar Rat as a Diabetic Model for Fracture Healing.

Authors:  Amit Sood; Catie Cunningham; Sheldon Lin
Journal:  ISRN Endocrinol       Date:  2013-03-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.